VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASH 2015 | Can we afford to have CLL patients on a therapy for the rest of their lives?

At the American Society of Hematology (ASH) 2015 Annual Meeting, John Gribben, MD, DSc and Stephan Stilgenbauer, MD discuss the challenges of long-term therapy in chronic lymphocytic leukemia (CLL) patients.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter